Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending November 2014. The document serves as a notification of transactions involving directors, persons discharging managerial responsibilities, or connected persons, specifically regarding changes in share interests.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific insider transaction and does not contain consolidated financial statements.
Material Changes
The filing details a transaction by Mr. N Hirons, a Person Discharging Managerial Responsibilities, on November 12, 2014:
- Exercise of options over 3,570 GSK American Depositary Shares (ADSs) granted on December 2, 2004, at a price of $43.73 per ADS.
- Sale of 2,286 ADSs at $45.70 per ADS.
- Sale of 1,284 ADSs at $45.72 per ADS.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is strictly a regulatory disclosure of an insider trade.
Key Facts for Investor Verification
- Verify the total number of ADSs held by Mr. N Hirons post-transaction to assess remaining exposure.
- Confirm the timing of the option grant (2004) relative to the exercise date (2014) to understand the vesting period.
- Check if similar transactions by other managerial personnel have occurred recently.